|Bid||0.00 x 1400|
|Ask||0.00 x 900|
|Day's Range||56.11 - 58.42|
|52 Week Range||56.11 - 69.75|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||1.96 (3.20%)|
|Ex-Dividend Date||Sep 30, 2021|
|1y Target Est||80.24|
These income stocks, with yields ranging from 1.8% to 7.4%, are the perfect place for investors to put their money to work during a downturn.
Which companies of today will stand the test of time? Here's why they picked Bristol Myers Squibb (NYSE: BMY), Pfizer (NYSE: PFE), and Johnson & Johnson (NYSE: JNJ). Prosper Junior Bakiny (Bristol Myers Squibb): Finding businesses that can stand the test of time is a challenging task.
At this time, I would like to turn the conference over to Mr. Tim Power, vice president investor relations. Joining me this morning with prepared remarks are Giovanni Caforio, our board chair and chief executive officer; and David Elkins, our chief financial officer. Also with me for today's call are Chris Boerner, our chief commercialization officer; and Samit Hirawat, our chief medical officer and head of global drug development.